Virtual reality visual field testing for people with open-angle glaucoma
Official title: Evaluation of the Accuracy and Reproducibility of Visual Field Testing Using a Virtual Reality Head-Mounted Device for Patients With Early, Moderate, and Advanced Glaucoma
Run by Nova Scotia Health Authority · NCT07063537 · Data updated 2026-11-12
This will test whether a virtual reality visual field test can match the standard Humphrey Field Analyzer for people with open‑angle glaucoma.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Nova Scotia Health Authority Academic / other |
| Locations | 1 site (Halifax, Nova Scotia) |
| Status | Recruiting |
| Started | December 14, 2024 |
| Main results expected | October 2025 |
| Study ends | October 2025 |
| Registry record updated | July 14, 2025 |
| Trial ID | NCT07063537 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 with a diagnosis of primary open‑angle glaucoma who can perform visual field testing and provide informed consent are ideal candidates.
✕Probably not a fit
Patients with secondary glaucoma or non‑glaucomatous optic neuropathy, significant media opacity, recent intraocular surgery (other than cataract or minimally invasive glaucoma surgery), or contraindications such as seizure disorder, pacemaker/implantable device, pregnancy, or severe vertigo are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study compares a Pico-based virtual reality (VR) visual field system directly with the Zeiss Humphrey Field Analyzer by having participants complete both tests in randomized order. Each participant will undergo testing for both eyes during five separate sessions at least 24 hours apart to measure global and pointwise thresholds and reproducibility. The study will examine whether glaucoma stage (early, moderate, advanced) or scotomas affect agreement between devices and will compare reliability indices. Participants will also complete a questionnaire about their experience with each test.
Why it matters
Potential benefit: If successful, this could provide a portable, less burdensome option to monitor visual field loss in glaucoma that performs similarly to the current clinical standard.
How similar studies have gone: Prior small studies of VR perimetry have shown promising agreement with standard perimeters, but larger reproducibility data are still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * \>18 years of age * diagnosis of primary open-angle glaucoma * ability to perform visual field testing * capacity to provide informed consent to research protocol Exclusion Criteria: * diagnosis of secondary glaucoma or non-glaucomatous optic neuropathy * previous intraocular surgery (excluding cataract surgery and minimally invasive glaucoma surgery) * significant media opacity * pregnancy * seizure disorder * cardiac pacemaker/other implantable device * severe vertigo/balance disorder
Where it's running
-
Eadie Technologies Inc
Halifax, Nova Scotia, Canada Recruiting
Study contacts
- Principal investigator: Brennan Eadie, MD, PhD, FRCSC — Nova Scotia Health
- Study coordinator: Reann Post, BSc
- Email: reann.post@dal.ca
- Phone: 19029560601
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Slow-coagulation trans-scleral cyclophotocoagulation versus trabeculectomy with mitomycin C for uncontrolled open-angle glaucoma after cataract surgery
This trial will test whether slow-coagulation trans-scleral cyclophotocoagulation or trabeculectomy with mitomycin C better lowers eye pressure in people over 40 with pseudophakic open-angle glaucoma not controlled by medications.
-
Evaluating the safety and effectiveness of iDose TR with cataract surgery
This study is testing if adding the iDose TR implant during cataract surgery can safely lower eye pressure better than just having cataract surgery alone for people with glaucoma or high eye pressure.
-
Electrical stimulation to improve vision in glaucoma
This trial will test whether a noninvasive transorbital alternating current stimulation device (EYETRONIC rtACS) can improve vision in adults with moderate open-angle glaucoma.
-
Comparing Hydrus Microstent and Goniotomy for Glaucoma Treatment
This study is testing whether the Hydrus Microstent works better than goniotomy for lowering eye pressure in people with mild to moderate glaucoma who are also having cataract surgery.
-
Comparing two treatments for glaucoma with cataract
This study is testing whether a new surgery for glaucoma combined with cataract removal works as well as the usual surgery plus eye drops for people with both conditions.
-
Comparison of Travoprost Implant with iStent Infinite vs. iStent Infinite Alone for Glaucoma
This study tests if combining a new eye implant with the iStent Infinite can lower eye pressure better than using the iStent Infinite alone in adults with glaucoma or high eye pressure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.